Grants for Public and State controlled institutions of higher education - Federal

The U.S. Department of States Bureau of Democracy, Human Rights, and Labor (DRL), in coordination with the Bureau of International Narcotic and Law Enforcement Affairs (INL), announces an open competition for organizations interested in submitting applications for a professional development program to strengthen the practical skills and resiliency of anticorruption actors to combat corruption more effectively in Central America.

This grant provides funding for researchers to conduct preclinical studies on the effects of radionuclide-based cancer therapies, aiming to improve treatment strategies and outcomes for cancer patients.

This funding opportunity is designed to establish a center that will coordinate and manage data for collaborative research on rare diseases, supporting various research consortia and engaging stakeholders to improve diagnosis and treatment.

The intent of this solicitation is to request proposals from organizations who are willing to serve as resource providers within the NSF Advanced Computing Systems and Services (ACSS) program. Resource providers would (1) provide advanced cyberinfrastructure (CI) resources in production operations to support the full range of computational- and data-intensive research across all of science and engineering (S), and (2) ensure democratized and equitable access to the proposed resources. The current solicitation is intended to complement previous NSF investments in advanced computational infrastructure by provisioning resources, broadly defined in this solicitation to include systems and/or services, in two categories: Category I, Capacity Resources: production computational resources maximizing the capacity provided to support the broad range of computation and data analytics needs in S research; and Category II, Innovative Prototypes/Testbeds: innovative forward-looking capabilities deploying novel technologies, architectures, usage modes, etc., and exploring new target applications, methods, and paradigms for S discoveries. Resource Providers supported via this solicitation will be incorporated into NSFs ACSS program portfolio. This program complements investments in leadership-class computing and funds a federation of nationally available HPC resources that are technically diverse and intended to enable discoveries at a computational scale beyond the research of individual or regional academic institutions. NSF anticipates that at least 90% of the provisioned resource will be available to the S community through an open peer-reviewed national allocation process and have resource users be supported by community and other support services. Such allocation and support services are expected to be coordinated through the NSF-funded Advanced Cyberinfrastructure Coordination Ecosystem: Services Support (ACCESS) suite of services, or an NSF-approved alternative as may emerge. If this is not feasible for the proposed resource, proposers must clearly explain in detail why this is the case and how they intend to make the proposed resource available to the national S community. The ACSS Program especially seeks broad representation of PIs (including women, underrepresented minorities, and individuals with disabilities)and institutions (including those that have not historically provided nationally allocatable cyberinfrastructure)in both the community of resource awardees and resources users to continue growing the scale and diversity of the S community.

This funding opportunity provides financial support for projects that promote U.S.-Angola and U.S.-São Tomé and Príncipe relations through education, cultural exchange, and professional development initiatives.

The "Clinical Trial Readiness to Understand and Develop Solutions to Social, Ethical, Behavioral Implications and Barriers to Health Equity in ADRD" grant aims to fund research that prepares for clinical trials focused on understanding and addressing the social, ethical, and behavioral barriers that prevent equal health outcomes for Alzheimer's Disease and Related Dementias (ADRD) in underserved and marginalized communities.

This funding opportunity provides financial support to organizations and institutions working to implement and promote research findings that improve the lives of individuals with disabilities through better community living, health, and employment outcomes.

With this solicitation, BJA seeks to support the development and testing of new or innovative approaches to improving community safety and trust that are alternatives to traditional enforcement mechanisms for neighborhoods experiencing high rates of less serious and low level criminal offenses. This model will involve coordination with law enforcement entities to improve public safety and community residents perceptions of law enforcement and procedural fairness and legitimacy. This solicitation also supports funding for national training and technical assistance (TTA) to support site-based grants and the field in building capacity and partnerships essential to this work.

This program funds projects that improve the safety, efficiency, and reliability of intercity passenger and freight rail. The Consolidated Rail Infrastructure and Safety Improvements (CRISI) Program is authorized under 49 U.S.C. 22907. The purpose of the CRISI Program is to invest in a wide range of projects within the United States to improve railroad safety, efficiency, and reliability; mitigate congestion at both intercity passenger rail and freight rail chokepoints to support more efficient travel and goods movement; enhance multi-modal connections; and lead to new or substantially improved Intercity Passenger Rail Transportation corridors. This program invests in railroad infrastructure projects that improve safety, support economic vitality (including through opportunities for small businesses), create good-paying jobs with the free and fair choice to join a union, increase capacity and supply chain resilience, apply innovative technology, and explicitly address climate change, gender equity and racial equity. The purpose of this notice is to solicit applications for the competitive CRISI Program provided in Consolidated Appropriations Act, 2023, division L, title I, Public Law 117–328 (2023 Appropriation), Consolidated Appropriations Act, 2024, division F, title I, Public Law 118–42 (2024 Appropriation) and the 2023 and 2024 advance appropriation in the Infrastructure Investment and Jobs Act, division J, title II, Public Law 117–58 (2021).

This grant provides funding for innovative research to develop organoid systems that can process information and interact with technology, targeting researchers and engineers in fields like biology, computer science, and engineering.

This initiative will support innovative, collaborative, and multi-disciplinary research designed to study the effective adaptation, integration, and implementation of recommended guidelines of care of persons with multiple chronic conditions (MCCs) from populations that experience health disparities. Projects would be expected to involve more than one component and/or more than one level of influence within existing or newly proposed health care models. The ultimate goal of this initiative is attainment of optimal treatment and health outcomes goals in order to move towards health equity.

This grant provides financial support and resources to early-career faculty from underrepresented backgrounds in neuroscience, helping them establish independent research careers through mentorship and protected research time.

This funding opportunity supports researchers and organizations conducting innovative studies and technology development related to ocean surface topography and its impact on Earth's systems.

This ISO seeks solution summaries and proposals for projects that fall within the general scope of the ARPA-H Scalable Solutions mission office. SSO expands what is technically possible by developing approaches that will leverage an interdisciplinary approach and collaborative networks to address challenges of geography, distribution, manufacturing, data and information, thereby improving health care access and affordability. In the United States, many communities and remote areas lack access to timely and quality health care, which leads to disparities in health outcomes for those populations. Bottlenecks during the manufacturing processes of products and health technologies also lead to delays and limited availability, preventing effective distribution of health care solutions to areas of need, especially in emergencies.ARPA-H SSO seeks solutions to improve the scalability and affordability of health care solutions, bridge gaps in underserved areas, and extend remote access to expertise by developing location-specific interventions, telemedicine solutions, and mobile health clinics. Solutions should focus on rapid innovation and the use of partnerships, as well as flexible distribution networks and streamlined manufacturing processes. The following SSO interest areas categorize the ground-breaking solutions we seek to support:Scalable Technologies and Interventions: Approaches to improve affordability and equitable access to health care that are adaptable to various geographic, demographic, economic contexts and can be rapidly deployed at scale (e.g., drug-repurposing*, telemedicine, point-of-care diagnostics, and modular health care infrastructure). Tailored solutions for the pediatric population that provide parity in access to treatments and other health care interventions with the adult population and adapt to the pediatric patients changing physiology and developmental status over the course of years. Transformational approaches to reduce or eliminate health disparities, including tools and models for product design and care delivery that scale novel approaches in human factors and human-centered design to respond to full diversity of patients. Tools to enable the scaling of provider and institutional capabilities (e.g., school nurses and schools, walk-in clinics, homesteading care) to address unmet health care access needs and expand availability of critical services. Foundational capabilities to accelerate diagnoses and reduce the cost of treatments for rare diseases wherever patients are, without the need for specialized facilities or healthcare expertise.* Solution summaries and proposals that focus on testing drugs for effectiveness for other disease states or use cases, are unlikely to be funded unless including additional R, or providing gains in cost reduction, accessibility, and/or equity.Collaborative Distribution Networks: Methods for standardization, automation, and democratization of complex procedures 5 including, but not limited to, histopathology, rare disease diagnosis and treatment, and surgical interventions to ensure access and delivery to populations diverse in demographics, geographies, and resources at scale. Approaches to enhance delivery of effective healthcare solutions in rural or low resource settings, including but not limited to "last mile delivery, at-home monitoring, imaging, drug delivery, telehealth augmentation, and support for remote medical procedures with limited need for specialized training. Technologies to enable the deployment of critical healthcare resources rapidly, equitably, and securely at scale to the point of need in permissive and non-permissive (i.e., damaged infrastructure, cyber-denied) environments during a public health crisis or natural disaster. Solutions to scale education and training of critical healthcare resources for health care providers and patients to ensure information integrity to prevent negative impacts to resource use/uptake. Innovative information technology, data and analytic products and technologies to enable ordering, inventory management, situational awareness, allocation planning and demand forecasting of critical healthcare resources during a public health crisis or natural disaster.Biomanufacturing Innovations*: Innovative manufacturing technologies and approaches that reduce cost, shorten the timeline for production, advance domestic competitiveness and reduce supply chain risk of biologics, cellular and gene therapies, pharmaceuticals, medical devices and personal protective equipment. New approaches to support predictable, programable biological production of conventional and novel materials reliability at scale in a cost-effective sustainable manner. Novel solutions to reduce the reliance on specialized handling and cold chain management of pharmaceuticals and biologics. Scalable innovations to advance and strengthen biomanufacturing supply chain and resolve bottlenecks including:o Advances in production of active pharmaceutical ingredients, process consumables, and other critical materials (i.e., enzymes, cell lines, etc);o Novel biomanufacturing-related data products, technologies or models to integrate into supply chain situational awareness systems;o Alternative materials and new manufacturing capabilities for personal protective equipment; ando Improvement of capabilities sustainably re-shore manufacturing and utilize a broad array of readily accessible and cost-efficient feedstocks as part of strengthening the local and national industry base. Analytics and novel sensor systems to precisely manage bioproduction, real-time release assays, and predictive capabilities to inform tuning of biological chassis for efficient and effective scale-up of manufacturing to industrial scale.*ARPA-H is not interested in approaches that merely increase capacity reservation.Other high-quality submissions that propose revolutionary technologies that meet the goals of SSO will be considered even if they do not address the topics listed above.Proposals are expected to use innovative approaches to enable revolutionary advances in medicine and healthcare, and the science and technology underlying these areas. While approaches that are disease agnostic are encouraged, ARPA-H welcomes proposals that bring radically new insights to address specific diseases including, but not limited to, cancer, diabetes, neurological diseases, pediatric and maternal/fetal health, infectious diseases, and cardiovascular disease.Specifically excluded are proposals that represent an evolutionary or incremental advance in the current state of the art or technology that has reached the clinical trial stage. An example of this type of proposal might include the request to fund clinical trials of an otherwise developed product. Additionally, proposals directed towards policy changes, traditional education and training, or center coordination, formation, or development, and construction of physical infrastructure are outside the scope of the ARPA-H mission.

Cooperative agreements under the Alzheimer's Disease Program Initiative (ADPI) Notice of Funding Opportunity (NOFO), are intended to support and promote the development and expansion of dementia-capable home and community-based service (HCBS) systems in States and Communities. There are two application options contained in this single NOFO: Grants to States (Option A) and Grants to Communities (Option B). No entity is eligible to apply for both State and Community options and no entity is eligible to hold more than one ADPI grant at a time. The dementia-capable systems resulting from program activities under either option are expected to provide quality, person-centered services and supports that help individuals living with dementia and their caregiver remain independent and safe in their communities.OPTION A: Grants to StatesApplicants for Option A (36 month cooperative agreements) are the governmental entities within states and territories designated as the state agency for dementia-capability and that have working relationships with their state agencies that enable creating and sustaining a dementia- capable HCBS System. Option A has two required objectives, the first of which is the creation, expansion and sustainability of a dementia-capable state HCBS system that includes Single Entry Point/No Wrong Door (SEP/NWD) access for people with dementia and their family caregivers. The second objective is to ensure access to a comprehensive, sustainable set of quality state HCBS that are dementia-capable and provide innovative services to the population with dementia and their caregivers.States and territories eligible for Option A are those that do not have active ACL ADPI State dementia-capability grants. All states without active grants are eligible to apply, however those states that have not benefited from ADSSP grants since before 2014 will be given priority consideration in the post-review decision-making process.OPTION B: Grants to CommunitiesCooperative agreements under Option B (36 month cooperative agreements) are available to private and/or public community-based organizations (CBO) that are able to: 1) demonstrate their operation within an existing dementia-capable HCBS system dedicated to the population that they serve; and 2) articulate opportunities and additional services in the targeted gap areas that would enhance and strengthen the existing system.Option B cooperative agreements are designed to aid community-based HCBS providers in addressing three specific service gaps in existing dementia-capable HCBS systems for persons living with or those at high risk of developing Alzheimers disease and related dementias (ADRD) and their caregivers.Option B applicants must address each of the following three gap areas:Provision of effective supportive services to persons living alone with ADRD in the community;Improvement of the quality and effectiveness of programs and services dedicated to individuals aging with intellectual and developmental disabilities with ADRD or those at high risk of developing ADRD; and Delivery of behavioral symptom management training and expert consultations for family caregivers.Community-based organizations are only eligible to hold one ADPI grant at a time. All community-based organizations without active ADPI grants are eligible to apply, however those that have not benefited from ADI-SSS and ADPI grant programs since before 2014 will be given priority consideration in the post-review decision-making process.

This funding opportunity supports partnerships that enhance research and education in astronomy and astrophysics, particularly for institutions serving historically underrepresented groups, by providing authentic research experiences and fostering an inclusive environment.

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on: (1) Courses for Skills Development; and (2) Develop and implement a program to prepare nurse scientists, and scientists in aligned fields, to conduct research on the social determinants of health in alignment with the NINR Strategic Plan.

This grant provides funding to U.S. and Cabo Verdean non-profit organizations and educational institutions for projects that promote cultural exchange, democratic governance, and economic growth between the United States and Cabo Verde.

The purpose of this NIDCD initiative is to encourage research in the development, characterization, and reproducibility/reliability of human auditory and vestibular organoids.Applications investigating animal organoids are allowable but only if accompanying comparative or other integrated companion studies with human organoids. Singular animal organoid studies alone are not responsive to this funding opportunity. This funding opportunity encourages innovative, reproducible, and novel methodologies and technologies that will drive the reproducibility and holistic longevity of hearing/balance sensory organoids as model systems. The development of novel tools to deliver genes, proteins, molecules, and synthetics that might lead to the successful expansion and longer-term survivability of organoid populations in a stable, reliable, and reproducible manner is highly encouraged. Subsequent characterization of the organoid platforms must be shown to mimic and recapitulate the native correlative biological function. Applications that provide approaches that remove current barriers and lessen challenges to improve current reproducibility and stability are highly encouraged. Applications that have breakthrough approaches and technologies using human auditory/vestibular organoids are highly encouraged.

Supports research on the processes by which energy in diverse forms is generated by the Sun, transported to the Earth, and ultimately deposited in the terrestrial environment. Major topics include space weather impacts, helioseismology, the solar dynamo, the solar activity cycle, magnetic flux emergence, solar flares and eruptive activity, coronal mass ejections, solar wind heating, solar energetic particles, interactions with cosmic rays, and solar wind/magnetosphere boundary problems. Upcoming due dates: Full proposal accepted anytime There are no deadlines or target dates for proposals sent in to any of the Geospace Section core programs. However, we recommend that PIs try to send in proposals early in the fiscal year. Program guidelines Apply to PD 98-1523 as follows: Full proposals submitted via Research.gov: NSF Proposal & Award Policies & Procedures Guide proposal preparation guidelines apply. Full proposals submitted via Grants.gov: NSF Grants.gov Application Guide guidelines apply. See Grants.gov Proposal Processing in Research.gov for more information.